APGE Cash-Secured Put Strategy

APGE (Apogee Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.

APGE (Apogee Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $8.18B, a beta of 0.62 versus the broader market, a 52-week range of 34.34-133.16, average daily share volume of 2.1M, a public-listing history dating back to 2023, approximately 196 full-time employees. These structural characteristics shape how APGE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.62 indicates APGE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on APGE?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current APGE snapshot

As of June 30, 2026, spot at $132.69, ATM IV 119.40%, IV rank 30.18%, expected move 34.23%. The cash-secured put on APGE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this cash-secured put structure on APGE specifically: APGE IV at 119.40% is mid-range versus its 1-year history, so the credit collected on a APGE cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 34.23% (roughly $45.42 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APGE expiries trade a higher absolute premium for lower per-day decay. Position sizing on APGE should anchor to the underlying notional of $132.69 per share and to the trader's directional view on APGE stock.

APGE cash-secured put setup

The APGE cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APGE near $132.69, the first option leg uses a $126.06 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APGE chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APGE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Sell 1	Put	$126.06	N/A

APGE cash-secured put risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

APGE cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on APGE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on APGE

Cash-secured puts on APGE earn premium while a trader waits to acquire APGE stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning APGE.

APGE thesis for this cash-secured put

The market-implied 1-standard-deviation range for APGE extends from approximately $87.27 on the downside to $178.11 on the upside. A APGE cash-secured put lets a trader earn premium while waiting to acquire APGE at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current APGE IV rank near 30.18% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on APGE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, APGE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APGE-specific events.

APGE cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APGE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APGE alongside the broader basket even when APGE-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on APGE carry tail risk when realized volatility exceeds the implied move; review historical APGE earnings reactions and macro stress periods before sizing. Always rebuild the position from current APGE chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on APGE?: A cash-secured put on APGE is the cash-secured put strategy applied to APGE (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With APGE stock trading near $132.69, the strikes shown on this page are snapped to the nearest listed APGE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are APGE cash-secured put max profit and max loss calculated?: Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the APGE cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 119.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a APGE cash-secured put?: The breakeven for the APGE cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APGE market-implied 1-standard-deviation expected move is approximately 34.23%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on APGE?: Cash-secured puts on APGE earn premium while a trader waits to acquire APGE stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning APGE.
How does current APGE implied volatility affect this cash-secured put?: APGE ATM IV is at 119.40% with IV rank near 30.18%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.